Global
Diabetes global report 2000 — 2050
- 589 million adults (20-79 years) are living with diabetes worldwide – 1 in 9.
- The total number of adults with diabetes is predicted to rise to 853 million by 2050 – 1 in 8.
- 4 in 5 adults with diabetes (81%) live in low and middle-income countries.
- Diabetes caused 3.4 million deaths in 2024 – 1 every 6 seconds.
- An estimated 43% of adults living with diabetes (252 million people) are undiagnosed. Almost 90% live in low and middle-income countries.
- Diabetes was responsible for an estimated USD 1.015 trillion in global health expenditure in 2024. This represents a 338% increase over the past 17 years.
- 635 million adults worldwide (1 in 8) have impaired glucose tolerance and 488 million have impaired fasting glucose (1 in 11) placing them at high risk of type 2 diabetes.
- 1 in 5 live births are affected by hyperglycaemia in pregnancy
At a glance
Global Data
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 151,000.0 | 366,000.0 | 588,715.6 | 852,472.1 |
Age-standardised prevalence of diabetes, % | 4.6 | 8.5 | 11.1 | 13.0 |
Proportion of people with undiagnosed diabetes, % | - | 50.0 | 42.8 | - |
People with undiagnosed diabetes, in 1,000s | - | 183,000.0 | 251,715.4 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 487,714.9 | 647,474.1 |
Age-standardised prevalence of IFG, % | - | - | 9.2 | 9.8 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 280,000.0 | 634,768.2 | 846,479.9 |
Age-standardised prevalence of IGT, % | - | 6.5 | 12.0 | 12.9 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 4,600,000.0 | 3,438,500.0 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 9.3 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | 23,333,164.5 | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | 15.6 | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | 2,301,922.9 | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | 2,561,740.2 | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | 465,000.0 | 1,014,758.3 | 1,043,208.0 |
Total diabetes-related health expenditure, ID million | - | 499,000.0 | 1,503,893.4 | 1,625,616.9 |
Diabetes-related health expenditure per person, USD | - | 1,274.0 | 1,760.3 | 1,253.1 |
Diabetes-related health expenditure per person, ID | - | 1,366.0 | 2,608.7 | 1,952.8 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 9,149,745.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 1,809,574.0 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 3,288,795.0 | 4,407,000.0 | 5,301,696.5 | 6,582,467.5 |
Population of children and adolescents (0-19 y) | - | - | 2,667,335,897.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 151,000.0 |
Age-standardised prevalence of diabetes, % | 4.6 |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 3,288,795.0 |
Population of children and adolescents (0-19 y) | - |